Occidental Petroleum (OXY) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
15 Oct, 2026Executive summary
2023 free cash flow was $5.5B; Q4 production reached 1,234 Mboed, and year-end proved reserves were 3.982B boe.
Q4 net income attributable to common stockholders was $1.029B, or $1.08 per diluted share; adjusted income was $710M, or $0.74 per diluted share.
Q4 operating cash flow was $3.2B; cash flow before working capital was $2.5B, and free cash flow before working capital was $1.1B.
Priorities include sustaining production and the dividend, reducing debt, and selectively investing in cash-flow growth and low-carbon opportunities.
Financial highlights
Q4 revenue was $7.529B; net income was $1.198B, including $1.029B attributable to common stockholders.
After-tax items affecting comparability totaled $319M, primarily a $283M fair-value gain related to the Carbon Engineering acquisition.
Q4 capital spending was $1.544B; $98M of noncontrolling-interest contributions brought net capital expenditures to $1.446B.
FY 2023 share repurchases totaled $1.8B, and more than $1.5B, or 15%, of preferred equity was redeemed.
Q4 OxyChem pretax income was $250M; Midstream and Marketing pretax income was $182M, including $149M of WES equity-method income.
Outlook and guidance
FY 2024 production guidance is 1,220–1,280 Mboed, excluding CrownRock; guidance assumes Gulf of Mexico third-party outage production returns March 1, 2024.
FY 2024 net capital expenditures are guided at $6.4–$6.6B, including $600M for emerging low-carbon businesses, net of noncontrolling-interest contributions.
FY 2024 OxyChem pretax income guidance is $1.0–$1.2B; adjusted effective tax rate is at least 30%, and interest expense is guided at $0.9B.
STRATOS is expected to become commercially operational in mid-2025; OxyChem projects are expected to deliver $300–$400M of annualized EBITDA from 2026 onward.
Latest events from Occidental Petroleum
- Q2 2026 saw $2.8B net income, record free cash flow, and an 8% dividend increase.OXY
Q2 2026 - Q1 2026 net income hit $3.2B, adjusted EPS $1.06, and debt fell by $7.1B.OXY
Q1 2026 - Record results, leadership change, and strong shareholder support for all proposals.OXY
AGM 2026 - Strong 2025 results, enhanced governance, and ESG focus drive key proxy votes and board actions.OXY
Proxy filing - Definitive additional proxy materials filed for shareholder voting, with no fee required.OXY
Proxy filing - Record production, cost savings, and debt reduction set the stage for resilient 2026 growth.OXY
Q4 2025 - Q3 2025 saw strong results and OxyChem sale, driving debt reduction and record production.OXY
Q3 2025 - Q3 2024 delivered record production, strong cash flow, and rapid debt reduction.OXY
Q3 2024 - Q2 net income up 64% to $992M; record production and CrownRock deal boost outlook.OXY
Q2 2024